Pneumonia, ventilator-associated (VAP): Difference between revisions

From CCMDB Wiki
Jump to navigation Jump to search
LKolesar (talk | contribs)
m some cleanup and rearranging, and integrating of Laura's answers into the text rather than as separate QnA in a different place in the page from the original instruction that is modified by it. .
Line 12: Line 12:


== Additional Info ==
== Additional Info ==
*This code supersedes the codes for bacterial, fungal and viral pneumonias. For example, if the patient qualifies for having a bacterial VAP, you code the VAP linked to the [[Pathogens|pathogen]], and you do NOT have to code [[Pneumonia, bacterial]].
*This code supersedes the codes for [[Pneumonia, bacterial]], [[Pneumonia, fungal/yeast]], [[Pneumonia, viral]] and [[Pneumonia, NOS]].  
{{Collapsable
| always=Example
| full=If the patient qualifies for having a bacterial VAP, you code the VAP linked to the [[Pathogens|pathogen]], and you do NOT have to code [[Pneumonia, bacterial]].}}
*Data collectors should '''follow criteria''' listed below regardless of what a physician writes in chart. If patient meets criteria VAP below, code as VAP.  If patient does not meet all listed criteria, then '''do not code as VAP'''. It may qualify as a [[HAP]] or [[CAP]].
*Data collectors should '''follow criteria''' listed below regardless of what a physician writes in chart. If patient meets criteria VAP below, code as VAP.  If patient does not meet all listed criteria, then '''do not code as VAP'''. It may qualify as a [[HAP]] or [[CAP]].
*A new VAP that is identified first on a medicine ward must be attributed to the ICU that sent the patient.
*While culture positivity of respiratory secretions are '''not''' part of the CDC definition below, you '''can use culture results of respiratory secretions to identify the [[Pathogen]] for your ICD10 Diagnosis''' (though positive blood or pleural fluid culture is considered more definitive).
*The only way VAP can be coded (as an admit code) on a medicine ward is if -- as per criterion #1 below -- the patient's Mechanical Ventilation (MV) ended that day or the prior day in an ICU AND patient met all the criteria.  
 
*If the medicine collector identifies that a new pneumonia is present soon after arrival to the ward, they should let the ICU collector know to assess whether it was a VAP or not. This can be put in the Admit code of the medicine collector but the sending ICU collector would have to ensure that the VAP is a complication for them and they have done the tmp information and notification process.
=== VAPs on medicine wards ===
*While culture positivity of respiratory secretions are '''not''' part of the CDC definition below, you '''can use culture results of respiratory secretions to identify the causative organism''' (though positive blood or pleural fluid culture is considered more definitive).
*The only way VAP can be coded (as an [[Admit Diagnosis]]) on a medicine ward is if -- as per criterion #1 below -- the patient's Mechanical Ventilation (MV) ended that day or the prior day in an ICU '''and''' patient met all the criteria.  
*If the medicine collector identifies that a new pneumonia is present soon after arrival to the ward, they should let the ICU collector know to assess whether it was a VAP or not. This can be put in the [[Admit Diagnosis]] of the medicine collector but the sending ICU collector would have to ensure that the VAP is a complication for them and they have done the tmp information and notification process.  


=== Onset of infection ===
=== Onset of infection ===
*If the symptoms of infection (pneumonia) are evident prior to being on MV for 48 hours, then it is not a VAP, even if the positive culture is done after the 48 hour mark.  
*If the '''symptoms''' of infection (pneumonia) are evident prior to being on mechanical ventilation for 48 hours, then it is not a VAP, even if the positive ''culture'' is done after the 48 hour mark.  


=== Recent previous pneumonia ===
*If a patient had any pneumonia previously during the same admission and then develops pneumonia again, meeting the VAP criteria, it is only a VAP if it is a new organism and has persistent or worsening infiltrates. If it is the same original organism, then the pneumonia has not completely been resolved, and you should NOT code it as a VAP.  
*If a patient had any pneumonia previously during the same admission and then develops pneumonia again, meeting the VAP criteria, it is only a VAP if it is a new organism and has persistent or worsening infiltrates. If it is the same original organism, then the pneumonia has not completely been resolved, and you should NOT code it as a VAP.  


Line 28: Line 33:
**An important consequence of this is that if on admission to the current unit it was NOT recognized that the patient has a VAP, but by these rules it is then figured out to be so --> THEN the correct coding of this VAP is as an '''[[Admit Diagnosis]]''', not an [[acquired diagnosis -- Tina please put this in for CLI too]].  
**An important consequence of this is that if on admission to the current unit it was NOT recognized that the patient has a VAP, but by these rules it is then figured out to be so --> THEN the correct coding of this VAP is as an '''[[Admit Diagnosis]]''', not an [[acquired diagnosis -- Tina please put this in for CLI too]].  
*The CDC case definition explicitly states that these rules should be followed -- that the physician’s statement of where the infection was acquired should not be substituted for these rules.
*The CDC case definition explicitly states that these rules should be followed -- that the physician’s statement of where the infection was acquired should not be substituted for these rules.
*A new VAP that is identified first on a medicine ward must be attributed to the ICU that sent the patient.


=== Long term ventilator patients with pneumonia ===
=== Long term ventilator patients with pneumonia ===
Line 35: Line 41:


===Data Collection Instructions===
===Data Collection Instructions===
If a patient meets all criteria of an '''[[Acquired Diagnosis / Complication]]''' of '''[[VAP]]''' while in your unit
If a patient meets all criteria of an '''[[Acquired Diagnosis / Complication]]''' of '''[[VAP]]''' while in your unit then enter tmp as per [[QA Infection VAP]].
then enter tmp as per in [[QA Infection VAP]].


===Criteria:  Must meet all of #1 + #2 + #3 + EITHER OF {#4 OR #5}===   
===Criteria:  Must meet (all of #1 + #2 + #3) + (EITHER OF #4 OR #5)===   
*These are the CDC criteria.
*These are the CDC criteria.


1.  VAP is an infectious pneumonia in a patient  who, as of the day it was identified (“day of event”) had been on mechanical ventilation (MV), either continuously or intermittently for at least 48 hours before onset of infection.  
1.  VAP is an infectious pneumonia in a patient  who, as of the day it was identified (“day of event”) had been on mechanical ventilation (MV), either continuously or intermittently for at least 48 hours before onset of infection.  
*The mechanical ventilation must be delivered via an endotracheal tube or tracheostomy.
*The mechanical ventilation must be delivered via an endotracheal tube or tracheostomy.


2.  Has at least ONE of the following 3 things:
2.  Has at least ONE of the following 3 things:
Line 49: Line 53:
*WBC<4000 or >12,000
*WBC<4000 or >12,000
*If >70 years old, altered mental status without another recognized cause
*If >70 years old, altered mental status without another recognized cause


3.  Chest imaging (X-ray) study or studies showing at least ONE of the following 3 things, that must be new & ''persistent'' OR ''progressive and persistent'': (CDC WORDING CHANGE).
3.  Chest imaging (X-ray) study or studies showing at least ONE of the following 3 things, that must be new & ''persistent'' OR ''progressive and persistent'': (CDC WORDING CHANGE).
Line 55: Line 58:
*Consolidation
*Consolidation
*Cavitation  
*Cavitation  


4. Has at least '''TWO''' of the following 4 things:
4. Has at least '''TWO''' of the following 4 things:
**New onset of purulent sputum or change in character of sputum, or increased respiratory secretions, or increased suctioning requirements.
*New onset of purulent sputum or change in character of sputum, or increased respiratory secretions, or increased suctioning requirements.
**New onset or worsening cough, or dyspnea, or tachypnea  
*New onset or worsening cough, or dyspnea, or tachypnea  
**Rales or bronchial breath sounds.
*Newly identified Rales or bronchial breath sounds.
**Worsening gas exchange -- e.g., O2 desaturations (e.g., PaO2/FiO2 <240), increased oxygen requirements, or increased ventilator demand
*Worsening gas exchange -- e.g., O2 desaturations (e.g., PaO2/FiO2 <240, arterial blood gas or pulse oximetry), increased oxygen requirements, or increased ventilator demand
 


5. Has at least '''ONE''' item in '''BOTH''' of lists 5A or 5B  
5. Has at least '''ONE''' item in '''BOTH''' of lists 5A or 5B  
Line 69: Line 70:
**New onset of purulent sputum or change in character of sputum, or increased respiratory secretions, or increased suctioning requirements.
**New onset of purulent sputum or change in character of sputum, or increased respiratory secretions, or increased suctioning requirements.
**New onset or worsening cough, or dyspnea, or tachypnea  
**New onset or worsening cough, or dyspnea, or tachypnea  
**Rales or bronchial breath sounds.
**Newly identified Rales or bronchial breath sounds.
**Worsening gas exchange -- e.g., O2 desaturations (e.g., PaO2/FiO2 <240), increased oxygen requirements, or increased ventilator demand
**Worsening gas exchange -- e.g., O2 desaturations (e.g., PaO2/FiO2 <240, arterial blood gas or pulse oximetry), increased oxygen requirements, or increased ventilator demand
 


*List 5B
*List 5B
Line 77: Line 77:
**Organism identified from pleural fluid (see pathogen exclusion list, below)
**Organism identified from pleural fluid (see pathogen exclusion list, below)
**Virus, Bordetella, Legionella, Chlamydia or Mycoplasma identified from respiratory secretions or tissue by a culture or non-culture based microbiologic testing method  
**Virus, Bordetella, Legionella, Chlamydia or Mycoplasma identified from respiratory secretions or tissue by a culture or non-culture based microbiologic testing method  
**In an immunocomprimised patient: identification of matching Candida from blood and sputum, endotracheal aspirate, BAL or protected specimen brushing. '''(NOTE:  THIS IS A NEW CDC ITEM)'''
**In an compromised patient: identification of matching Candida from blood and sputum, endotracheal aspirate, BAL or protected specimen brushing. '''(This is a new CDC item)'''
**In an immunocomprimised patient: Evidence of fungi [i.e. MYCELIA, NOT YEAST] from BAL or protected specimen brushing)'''(NOTE: THIS IS A NEW CDC ITEM)'''. Be aware that fungi is not the same as yeast (do not use candida spp).https://www.cdc.gov/fungal/diseases/index.html
**In an compromised patient: Evidence of fungi (i.e. mycelia, not yeast) from BAL or protected specimen brushing)'''(This is a new CDC item)'''. Be aware that fungi is not the same as yeast (do not use candida spp). https://www.cdc.gov/fungal/diseases/index.html
**Positive quantitative culture, performed according to accepted protocols, from bronchoalveolar lavage or protected brush specimens (see pathogen exclusion list, below) (NOTE:  For clarification, regarding the "quantitative culture", Dr. Garland says this is not done very often if ever and he has actually never seen one done at HSC. Most bronchs are not "quantitative" so for most intents and purposes a BAL culture is not valid for use in the VAP criteria unless candida is cultured in immunocompromised patients only and only if the patient also has a matching blood culture. --[[User:LKolesar|LKolesar]] 09:55, 2018 July 26 (CDT)
**Positive quantitative culture, performed according to accepted protocols, from bronchoalveolar lavage or protected brush specimens (see pathogen exclusion list, below) (NOTE:  For clarification, regarding the "quantitative culture", Dr. Garland says this is not done very often if ever and he has actually never seen one done at HSC. Most bronchoscopies are not "quantitative" so for most intents and purposes a BAL culture is not valid for use in the VAP criteria unless candida is cultured in immunocompromised patients only and only if the patient also has a matching blood culture. --[[User:LKolesar|LKolesar]] 09:55, 2018 July 26 (CDT)


**>5% of cells obtained from bronchoalveolar lavage contain intracellular bacteria on direct microscopic exam
**>5% of cells obtained from bronchoalveolar lavage contain intracellular bacteria on direct microscopic exam
**Positive culture of lung tissue (see pathogen exclusion list, below)
**Positive culture of lung tissue (see pathogen exclusion list, below)
**Histopathologic exam of lung tissue identifies abscess formation, or foci of consoliation with intense PMN accumulation in bronchioles and alveoli
**Histopathologic exam of lung tissue identifies abscess formation, or foci of consolidation with intense PMN accumulation in bronchioles and alveoli
**Histopathologic exam of lung tissue identifies lung invasion of fungal hyphae or pseudohyphae
**Histopathologic exam of lung tissue identifies lung invasion of fungal hyphae or pseudohyphae
**Fourfold rise in paired sera (IgG) for pathogen (e.g., influenza viruses, Chlamydia)  
**Fourfold rise in paired sera (IgG) for pathogen (e.g., influenza viruses, Chlamydia)  
**Fourfold rise in Legionella pneumophila serogroup 1 antibody titer to ≥1:128 in paired acute and convalescent sera by indirect IFA.  
**Fourfold rise in Legionella pneumophila serogroup 1 antibody titer to ≥1:128 in paired acute and convalescent sera by indirect IFA.  
**Detection of L. pneumophila serogroup 1 antigens in urine by RIA or EIA  
**Detection of L. pneumophila serogroup 1 antigens in urine by RIA or EIA  
***("NOTE that ETT secretion(sputum) culture is NOT part of the criteria -- the reason is that sputum is virtually never culture negative in intubated patients, even without infection." We will still put the ETT pathogen in the diagnostic codes if it is available, even though the positive culture is not part of the criteria.)
***(ETT secretion(sputum) culture is NOT part of the criteria -- the reason is that sputum is virtually never culture negative in intubated patients, even without infection. We will still enter the ETT pathogen as [[ICD10]] [[pathogen]] if it is available, even though the positive culture is not part of the criteria.)


* '''See below for detailed list of '''all possible sources''' for cultures: {{Discuss | who=all |question = where is that list of sources, did it get lost in an edit? }}


'''* See below for detailed list of '''all possible sources''' for cultures:
===VAP Pathogens Exclusion List===
 
===VAP Pathogens Excluson List===
'''NEW CDC LIST'''  (does not include candida b/c can be a valid pathogen in immunocompromised pts who have candida in both blood and ETT cultures (see list 5B, above)
'''NEW CDC LIST'''  (does not include candida b/c can be a valid pathogen in immunocompromised pts who have candida in both blood and ETT cultures (see list 5B, above)
*Normal respiratory flora
*Normal respiratory flora
Line 109: Line 108:
*Some Notes:
*Some Notes:
**Prior colonization with MRSA does not exclude it from causing VAP, if they meet the listed criteria.
**Prior colonization with MRSA does not exclude it from causing VAP, if they meet the listed criteria.


=== CXR's===  
=== CXR's===  
Line 115: Line 113:
*If, in real time, you are seeing that a ventilated patient qualifies for a VAP ''except'' that a followup CXR wasn't done to demonstrate persistence, you should point out to the physician(s) that the CDC criterion require infiltrates be persistent by chest imaging and therefore we would require a followup CXR to confirm the diagnosis.  Refer them to Dr. Garland if there's resistance to this.
*If, in real time, you are seeing that a ventilated patient qualifies for a VAP ''except'' that a followup CXR wasn't done to demonstrate persistence, you should point out to the physician(s) that the CDC criterion require infiltrates be persistent by chest imaging and therefore we would require a followup CXR to confirm the diagnosis.  Refer them to Dr. Garland if there's resistance to this.


=== Notes for Collectors ===
=== Sputum cultures ===
*NOTE that sputum culture is NOT part of the criteria -- the reason is that sputum is ''virtually never'' culture negative in intubated patients, even without infection.
Sputum culture is NOT part of the criteria -- the reason is that sputum is ''virtually never'' culture negative in intubated patients, even without infection.
*Following CDC criteria, we will not code "presumed VAP".
 
*There are no guidelines for CAP developing VAP, other than meeting the VAP criteria. For example, the idea of a CXR showing a "New and persistent" or "Progressive and Persistent" infiltrate allows for coding a second pneumonia on top of a first one.
=== No such thing as "presumed VAP" ===
**Questions with answers:
Following CDC criteria, we will not code "presumed VAP".
*1. The criterion "rales or bronchial breath sounds" does not clarify whether this is a new finding for that patient.  Some patients have on-going chest sounds that indicate this and when being assessed for a VAP it is still there. Should this be used as part of the VAP criteria in these patients?  Dr. Garland stated that if a given item in the list is already present or OLD then it should not be counted as part of the criterion for a VAP.  Only use NEW presentation of the criterion. 
 
*2. The criterion for "worsening gas exchange" gives an example of O2 desaturations (eg. PaO2/FiO2<240), increased oxygen requirements, or increased ventilator demand. I asked if a patient's vent settings are unchanged and there are no arterial gases done (only venous), what is the best way to assess this criterion?  Dr. Garland stated that venous gases cannot be used to gauge oxygenation.  For the assessment of this criterion, use arterial gases or pulse oximetry for desaturations.
=== '''No special rules''' for "CAP developing VAP" ===
There are no guidelines for CAP developing VAP, other than meeting the VAP criteria. For example, the idea of a CXR showing a "New and persistent" or "Progressive and Persistent" infiltrate allows for coding a second pneumonia on top of a first one.


== Alternate ICD10s to consider coding instead or in addition ==
== Alternate ICD10s to consider coding instead or in addition ==

Revision as of 17:15, 1 October 2018

ICD10 Diagnosis
Dx: Pneumonia, ventilator-associated (VAP)
ICD10 code: J95.88
Pre-ICD10 counterpart: VAP - Ventilator Associated Pneumonia
Charlson/ALERT Scale: none
APACHE Como Component: none
APACHE Acute Component: none
Start Date:
Stop Date:
Data Dependencies(Reports/Indicators/Data Elements): No results
External ICD10 Documentation

This diagnosis is a part of ICD10 collection.

  • SMW
    • 2019-01-01
    • 2999-12-31
    • J95.88
  • Cargo


  • Categories
  • SMW
  • Cargo


  • Categories
  • SMW
  • Cargo


  • Categories
  • SMW
  • Cargo


  • Categories
  • SMW
  • Cargo


  • Categories
  • SMW
  • Cargo


  • Categories

Additional Info

Example   

If the patient qualifies for having a bacterial VAP, you code the VAP linked to the pathogen, and you do NOT have to code Pneumonia, bacterial.

  • Data collectors should follow criteria listed below regardless of what a physician writes in chart. If patient meets criteria VAP below, code as VAP. If patient does not meet all listed criteria, then do not code as VAP. It may qualify as a HAP or CAP.
  • While culture positivity of respiratory secretions are not part of the CDC definition below, you can use culture results of respiratory secretions to identify the Pathogen for your ICD10 Diagnosis (though positive blood or pleural fluid culture is considered more definitive).

VAPs on medicine wards

  • The only way VAP can be coded (as an Admit Diagnosis) on a medicine ward is if -- as per criterion #1 below -- the patient's Mechanical Ventilation (MV) ended that day or the prior day in an ICU and patient met all the criteria.
  • If the medicine collector identifies that a new pneumonia is present soon after arrival to the ward, they should let the ICU collector know to assess whether it was a VAP or not. This can be put in the Admit Diagnosis of the medicine collector but the sending ICU collector would have to ensure that the VAP is a complication for them and they have done the tmp information and notification process.

Onset of infection

  • If the symptoms of infection (pneumonia) are evident prior to being on mechanical ventilation for 48 hours, then it is not a VAP, even if the positive culture is done after the 48 hour mark.

Recent previous pneumonia

  • If a patient had any pneumonia previously during the same admission and then develops pneumonia again, meeting the VAP criteria, it is only a VAP if it is a new organism and has persistent or worsening infiltrates. If it is the same original organism, then the pneumonia has not completely been resolved, and you should NOT code it as a VAP.

Attribution of the VAP to a Hospital Location

  • The infection is attributed to the location where the patient was on the date the infection became clinically evident -- EXCEPT if all elements of the infection are present within the first 48 hours of arrival, the infection is attributed to the location from which they were transferred.
  • The CDC case definition explicitly states that these rules should be followed -- that the physician’s statement of where the infection was acquired should not be substituted for these rules.
  • A new VAP that is identified first on a medicine ward must be attributed to the ICU that sent the patient.

Long term ventilator patients with pneumonia

  • If a LTV patient is admitted from the community with a pneumonia, a Community Acquired Pneumonia (Community-acquired pneumonia (CAP) in ICD10) should be coded, not VAP, even though it is technically a VAP.
    • The rationale for this is that we only are wanting to tracking Hospital Acquired VAP's, not patients who have acquired an pneumonia while on long term home ventilators (LTV) in the community.
  • Of course, if the patient entered the hospital without a pneumonia, and develops one (and meets the VAP criteria), then that person would have a VAP we do want to code.

Data Collection Instructions

If a patient meets all criteria of an Acquired Diagnosis / Complication of VAP while in your unit then enter tmp as per QA Infection VAP.

Criteria: Must meet (all of #1 + #2 + #3) + (EITHER OF #4 OR #5)

  • These are the CDC criteria.

1. VAP is an infectious pneumonia in a patient who, as of the day it was identified (“day of event”) had been on mechanical ventilation (MV), either continuously or intermittently for at least 48 hours before onset of infection.

  • The mechanical ventilation must be delivered via an endotracheal tube or tracheostomy.

2. Has at least ONE of the following 3 things:

  • Fever > 38.0
  • WBC<4000 or >12,000
  • If >70 years old, altered mental status without another recognized cause

3. Chest imaging (X-ray) study or studies showing at least ONE of the following 3 things, that must be new & persistent OR progressive and persistent: (CDC WORDING CHANGE).

  • Infiltrate
  • Consolidation
  • Cavitation

4. Has at least TWO of the following 4 things:

  • New onset of purulent sputum or change in character of sputum, or increased respiratory secretions, or increased suctioning requirements.
  • New onset or worsening cough, or dyspnea, or tachypnea
  • Newly identified Rales or bronchial breath sounds.
  • Worsening gas exchange -- e.g., O2 desaturations (e.g., PaO2/FiO2 <240, arterial blood gas or pulse oximetry), increased oxygen requirements, or increased ventilator demand

5. Has at least ONE item in BOTH of lists 5A or 5B

  • List 5A [Yes, this is the same list as in #4, but here it's just 1 item instead of 2 items]
    • New onset of purulent sputum or change in character of sputum, or increased respiratory secretions, or increased suctioning requirements.
    • New onset or worsening cough, or dyspnea, or tachypnea
    • Newly identified Rales or bronchial breath sounds.
    • Worsening gas exchange -- e.g., O2 desaturations (e.g., PaO2/FiO2 <240, arterial blood gas or pulse oximetry), increased oxygen requirements, or increased ventilator demand
  • List 5B
    • Organism identified from blood (see pathogen exclusion list, below)
    • Organism identified from pleural fluid (see pathogen exclusion list, below)
    • Virus, Bordetella, Legionella, Chlamydia or Mycoplasma identified from respiratory secretions or tissue by a culture or non-culture based microbiologic testing method
    • In an compromised patient: identification of matching Candida from blood and sputum, endotracheal aspirate, BAL or protected specimen brushing. (This is a new CDC item)
    • In an compromised patient: Evidence of fungi (i.e. mycelia, not yeast) from BAL or protected specimen brushing)(This is a new CDC item). Be aware that fungi is not the same as yeast (do not use candida spp). https://www.cdc.gov/fungal/diseases/index.html
    • Positive quantitative culture, performed according to accepted protocols, from bronchoalveolar lavage or protected brush specimens (see pathogen exclusion list, below) (NOTE: For clarification, regarding the "quantitative culture", Dr. Garland says this is not done very often if ever and he has actually never seen one done at HSC. Most bronchoscopies are not "quantitative" so for most intents and purposes a BAL culture is not valid for use in the VAP criteria unless candida is cultured in immunocompromised patients only and only if the patient also has a matching blood culture. --LKolesar 09:55, 2018 July 26 (CDT)
    • >5% of cells obtained from bronchoalveolar lavage contain intracellular bacteria on direct microscopic exam
    • Positive culture of lung tissue (see pathogen exclusion list, below)
    • Histopathologic exam of lung tissue identifies abscess formation, or foci of consolidation with intense PMN accumulation in bronchioles and alveoli
    • Histopathologic exam of lung tissue identifies lung invasion of fungal hyphae or pseudohyphae
    • Fourfold rise in paired sera (IgG) for pathogen (e.g., influenza viruses, Chlamydia)
    • Fourfold rise in Legionella pneumophila serogroup 1 antibody titer to ≥1:128 in paired acute and convalescent sera by indirect IFA.
    • Detection of L. pneumophila serogroup 1 antigens in urine by RIA or EIA
      • (ETT secretion(sputum) culture is NOT part of the criteria -- the reason is that sputum is virtually never culture negative in intubated patients, even without infection. We will still enter the ETT pathogen as ICD10 pathogen if it is available, even though the positive culture is not part of the criteria.)
  • See below for detailed list of all possible sources for cultures:

where is that list of sources, did it get lost in an edit?

  • SMW


  • Cargo


  • Categories

VAP Pathogens Exclusion List

NEW CDC LIST (does not include candida b/c can be a valid pathogen in immunocompromised pts who have candida in both blood and ETT cultures (see list 5B, above)

  • Normal respiratory flora
  • Normal oral flora
  • Mixed respiratory flora
  • Cagulase-negative staph species (includes S. epidermidis, does not include S. aureus)
  • Enterococcus species
  • Blastomyces species (blasto)
  • Histoplasma species
  • Coccidioides species
  • Paracoccidioides species
  • Cryptococcus species
  • Pneumocystis species
  • Patients might be treated for infection with these pathogens, but we should still not code them as VAP. In that case you might be able to code it as a Hospital-acquired pneumonia (HAP) in ICD10 or Community-acquired pneumonia (CAP) in ICD10.
  • Some Notes:
    • Prior colonization with MRSA does not exclude it from causing VAP, if they meet the listed criteria.

CXR's

  • Because it is well recognized that there are many non-infectious reasons for fleeting infiltrates in intubated ICU patients, Criterion#3 above requires that the listed changes be either "New and Persistent" or "Progressive and Persistent". This necessarily means that there must be >1 CXR -- preferably over more than 1 day -- showing the "persistence".
  • If, in real time, you are seeing that a ventilated patient qualifies for a VAP except that a followup CXR wasn't done to demonstrate persistence, you should point out to the physician(s) that the CDC criterion require infiltrates be persistent by chest imaging and therefore we would require a followup CXR to confirm the diagnosis. Refer them to Dr. Garland if there's resistance to this.

Sputum cultures

Sputum culture is NOT part of the criteria -- the reason is that sputum is virtually never culture negative in intubated patients, even without infection.

No such thing as "presumed VAP"

Following CDC criteria, we will not code "presumed VAP".

No special rules for "CAP developing VAP"

There are no guidelines for CAP developing VAP, other than meeting the VAP criteria. For example, the idea of a CXR showing a "New and persistent" or "Progressive and Persistent" infiltrate allows for coding a second pneumonia on top of a first one.

Alternate ICD10s to consider coding instead or in addition

Pneumonia codes:

Candidate Combined ICD10 codes

Infections

Infections in ICD10 have combined coding requirements for some of their pathogens. Any that have antibiotic resistances would store those as Combined ICD10 codes as well. If the infection is acquired in the hospital, see Nosocomial infection, NOS. See Lab and culture reports for confirmation and details about tests. See Infections in ICD10 for more general info.

Possible Simultaneous Presence of Multiple Different Types of Infection in a Single Site

  • This refers to the situation where there may be simultaneous infection with multiple types of organisms -- e.g. 2 of bacteria, virus, fungus. While a classic example is a proven viral pneumonia (e.g. influenza) with a suspected/possible bacterial pneumonia superimposed, this kind of thing can occur in places other than the lungs, e.g. meningitis.
    • The "signature" of this is typically the patient being treated simultaneously with antimicrobial agents for multiple types of organisms. BUT don't confuse this with there being infections at DIFFERENT body sites.
  • As per our usual practice, we will consider a diagnosis as present if the clinical team thinks it's present and are treating it, with the exception that the team initially treated for the possible 2nd type of infection but then decided it likely was NOT present and stopped those agents.
  • And remember that Infectious organism, unknown is used when the the specific organism is unknown (this could be not knowing the TYPE of organism, or suspecting the type but not having identified the specific organism of that type), while when the organism has been identified but it's not in our bug list, THEN use Bacteria, NOS, Virus, NOS or Fungus or yeast, NOS.

Attribution of infections

See Attribution of infections


Related CCI Codes

Data use

Used in:

Reporting of complication when patients move units

The Ventilator Associated Pneumonia Rate we report are based only on Acquired Diagnosis / Complication occurring in a unit. If VAP is coded as an Admit Diagnosis, we check if the patient came from one of the ICUs where we collect data, and if so, make sure that the VAP is coded as a Acquired Diagnosis / Complication and QA Infection VAP there.

If a VAP Admit Diagnosis doesn't have a corresponding Acquired Diagnosis / Complication in the previous unit, the data processor will ask the collector to audit.

Criteria change

The update in criteria in 2017-11 will likely lead to a higher rate of identifying VAPs. This needs to be noted in reports.


Related articles:

Template:Discussion


Show all ICD10 Subcategories

ICD10 Categories: ANCA-associated Vasculitis (AAV), Abdominal trauma, Abortion, Acute intoxication, Addiction, Adrenal Insufficiency, Adverse effect, Alcohol related, Allergy, Anemia, Anesthetic related, Aneurysm, Antibiotic resistance, Antidepressant related, Aortic Aneurysm, Arrhythmia, Arterial thromboembolism, Asthma, Atherosclerosis, Awaiting/delayed transfer, Bacteria, Benign neoplasm, Breast disease, Burn, COVID, Cannabis related, Cardiac septum problem, Cardiovascular, Cerebral Hemorrhage/Stroke, Chemical burn, Chronic kidney disease, Cirrhosis, Cocaine related, Decubitus Deep Tissue Damage, Decubitus Stage 1, Decubitus Stage 2, Decubitus Stage 3, Decubitus Stage 4, Decubitus Stage not indicated, Decubitus heel, Decubitus other area, Decubitus sacral area, Decubitus ulcer, Delirium, Dementia, Diabetes, Diagnosis implying death, Double duty pathogen, ENT, Electrolyte disturbance, Encephalitis, Encephalopathy, Endocrine disorder, Endocrine neoplasm, Exposure, Eye, Female genital neoplasm, Fistula, Fracture, Fungus, GI ulcer, Gastroenteritis, Gastrointestinal, Gastrointestinal neoplasm, Hallucinogen related, Has one, Head trauma, Head trauma (old), Healthcare contact, Heart valve disease, Heme/immunology, Heme/immunology neoplasm, Hemophilia, Hemorrhage, Hepatitis, Hereditary/congenital, Hernia, Hypertension, Hypotension, Iatrogenic, Iatrogenic infection, Iatrogenic mechanism, Imaging, Infection requiring pathogen, Infection with implied pathogen, Infectious disease, Inflammatory Bowel Disease, Influenza, Inhalation, Intra-abdominal infection, Ischemia, Ischemic gut, Ischemic heart disease, Joint/ligament trauma, Leukemia, Liver disease, Liver failure, Lower limb trauma, Lower respiratory tract infection, Lymphoma... further results